Dupilumab in Pediatric Eosinophilic Esophagitis: Efficacy, Safety, and Translational Insights from Recent Clinical Evidence
This review synthesizes current pediatric data on dupilumab for eosinophilic esophagitis, highlighting high remission rates, treatment deescalation, and safety, supported by mechanistic and clinical trial evidence.